
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Zydus Lifesciences launches Rexigo , the oral once-a-day pill for advanced prostate cancer patients in India".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Zydus Lifesciences launches Rexigo , the oral once-a-day pill for advanced prostate cancer patients in India".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences